Trichomoniasis is the most common nonviral sexually transmitted infection (STI) worldwide with an estimated incidence of 276 million new cases annually (
1,
2). Trichomoniasis is attributed to
Trichomonas vaginalis as an anaerobic, flagellated protozoan parasite. Although
T. vaginalis affects both men and women, manifestations of trichomoniasis are primarily observed in women (
1). In most cases, trichomoniasis tends to be clinically asymptomatic in women and one-third of asymptomatic women become symptomatic within six months (
3). The symptoms among women include vaginal discharge (which is often diffuse, malodorous, and yellow-green), dysuria, itching, vulvar irritation, and abdominal pain (
3). Trichomoniasis can increase the risk of acquiring or spreading other STIs, as it brings a greater risk of HIV acquisition and transmission (1.5 - 2.7 times) (
1) and creates nearly a four-fold increase in HIV shedding (
4). Wet mount microscopy is the most commonly used test for detecting
T. vaginalis in cervicovaginal specimens, with a sensitivity of 51% to 65% (
4). For many years, the culturing technique has been the accepted gold standard for diagnosing
T. vaginalis infection, with a sensitivity of 85% - 95% (
5). However, this procedure is rather time-consuming and costly. Most importantly, the need for return visits can be a barrier to proper treatment. The sensitivity of the culture method is much less than the sensitivity of nucleic acid amplification tests, including polymerase chain reaction (PCR) (
1). However, the determination of
T. vaginalis genotypes in asymptomatic or symptomatic patients can represent an image of the epidemiology of the parasite in the region (
6,
7).
In some regions of Iran, the prevalence rate of trichomoniasis has been determined between 2% and 8%; the rates can also reach up to 30% depending on the cultural and social status (
8-
11). So far, no reliable study has been performed on the epidemiology of
T. vaginalis in Southeast of Iran.